915
Participants
Start Date
December 31, 2011
Primary Completion Date
November 30, 2015
Study Completion Date
January 31, 2016
Certolizumab Pegol (CZP)
"* Active substance: an injectable volume of 1 ml solution for injection CZP~* Pharmaceutical form: prefilled syringes CZP~* Concentration: 200 mg/ml CZP~* Route of Administration: injections will be given subcutaneously: loading dose of CZP 400 mg at Baseline, and Weeks 2 and 4, followed by a maintenance dose of 200 mg every 2 weeks through Week 102 or withdrawal."
Adalimumab (ADA)
"* Active substance: an injectable volume of 0.8 ml solution for injection ADA~* Pharmaceutical form: prefilled syringes ADA~* Concentration: 40 mg/0.8 ml ADA~* Route of Administration: injections will be given subcutaneously. ADA 40 mg plus an injection with Placebo (to preserve blind) at Baseline, and Weeks 2 and 4, followed by ADA 40 mg every 2 weeks through Week 102 or withdrawal."
Methotrexate (MTX)
"* Active substance: Methotrexate~* Pharmaceutical form: oral tablet~* Concentration: 15-25 mg/week~* Route of Administration: MTX orally"
141, Birmingham
214, Tuscaloosa
159, Tucson
152, Hot Springs
147, Covina
161, Fullerton
217, La Mesa
149, Los Angeles
144, Menifee
185, Roseville
208, Sacramento
189, Van Nuys
148, Whittier
220, Lewes
142, Aventura
216, Fort Lauderdale
162, Gainesville
209, Vero Beach
145, Coeur d'Alene
202, Maywood
134, Lexington
178, Baltimore
137, Battle Creek
153, Detroit
155, Lansing
204, Eagan
180, Rochester
143, Saint Louis Park
135, Omaha
170, Reno
201, Teaneck
150, Voorhees Township
205, Albuquerque
154, Albany
136, Brooklyn
219, Orchard Park
207, Plainview
167, Syracuse
140, Cincinnati
184, Oklahoma City
164, Bethlehem
132, Duncansville
190, Wyomissing
210, Charleston
187, Myrtle Beach
203, Orangeburg
133, Jackson
160, Knoxville
138, Austin
151, Corpus Christi
131, Dallas
146, Dallas
213, Dallas
166, Houston
212, Houston
139, San Antonio
181, Sugar Land
165, Victoria
211, Arlington
157, Spokane
163, Clarksburg
215, Glendale
6, Camperdown
5, Kogarah
2, Maroochydore
4, Hobart
7, Clayton
8, Fitzroy
1, Malvern
3, Subiaco
85, Stockerau
22, Vienna
18, Pleven
35, Plovdiv
21, Sofia
29, Sofia
34, Sofia
46, Sofia
179, Edmonton
168, St. John's
176, St. John's
183, Halifax
172, Hamilton
174, Hamilton
177, Ottawa
206, Ottawa
175, St. Catharines
218, Rimouski
169, Sainte-Foy
221, Barrie
171, Québec
103, Brno
61, Hradec Králové
58, Pilsen
49, Prague
40, Uherské Hradiště
89, Brest
70, Le Mans
62, Lyon
72, Montpellier
90, Orléans
105, Toulouse
56, Berlin
64, Cologne
47, Fulda
17, Hamburg
31, Heidelberg
37, Herne
63, Osnabrück
11, Ratingen
66, Rheine
48, Rostock
71, Traunstein
44, Zerbst
94, Heraklion
95, Larissa
13, Budapest
42, Budapest
68, Gyula
100, Kistarcsa
43, Szeged
33, Veszprém
23, Dublin
51, Dublin
20, Limerick
80, Bergamo
38, Genova
88, Genova
79, Magenta
98, Napoli
67, Prato
36, Roma
39, Verona
194, Chihuahua City
195, Chihuahua City
193, Guadalajara
192, Monterrey
191, San Luis Potosí City
60, Monaco
107, Bydgoszcz
106, Poznan
113, Warsaw
115, Warsaw
108, Wroclaw
69, Coimbra
27, Lisbon
76, Lisbon
14, Ponte de Lima
81, Porto
54, Bacau
74, Brăila
24, Bucharest
25, Bucharest
28, Bucharest
32, Bucharest
57, Bucharest
12, Cluj-Napoca
96, Galati
26, Iași
16, A Coruña
52, A Coruña
30, Madrid
83, Madrid
82, Sabadell
65, Vigo
53, Sankt Gallen
50, Zurich
86, Ashford
78, Brighton
59, Leeds
19, London
77, Poole
55, Sheffield
73, Upton
99, Wigan
Collaborators (1)
Parexel
INDUSTRY
UCB Pharma SA
INDUSTRY